Abstract
SINCE its introduction as a treatment for ascites in 1974, the LeVeen peritoneovenous shunt has seen expanded use in certain medical centers. Preliminary results generally have been favorable,<sup>1-4</sup>although unsatisfactory outcomes are reported.<sup>3,5,6</sup>Many are encouraged by the often quick, readily quantifiable results obtained with this device in conditions whose traditional medical treatment may imply prolonged hospitalization and many times results in only temporary improvement. The peritoneovenous shunt is now increasingly being recommended for all patients who either do not respond to medical therapy with a prompt loss of their ascites or who are difficult to treat medically.<sup>7</sup> <h3>Report of a Case</h3> This was the second Thomas Jefferson University Hospital (Philadelphia) admission for a 65-year-old male chronic alcoholic whose chief complaints were dyspnea and increasing abdominal girth. The patient had been well until Oct 3, 1977, when he came to the Jefferson Accident Ward with a new onset
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
